Bausch Health Co. Inc. (BHC) Reports In-Line Q2 Revenue, Updates Guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of ($1.66), may not compare to the analyst estimate of $0.95. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.12 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2021 revenue of $8.4-8.6 billion, versus the consensus of $8.64 billion.

• Full-year revenue range of $8.60 – $8.80 billion to $8.40 – $8.60 billion
• Full-year Adjusted EBITDA (non-GAAP) range of $3.40 – $3.55 billion to $3.35 – $3.50 billion

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge